Total Payments
$2,624
2024 Payments
$865.10
Companies
24
Transactions
146
Medicare Patients
1,536
Medicare Billing
$60,390
Payment Breakdown by Category
Food & Beverage$2,624 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,624 | 146 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $786.89 | 30 | $0 (2024) |
| ABBVIE INC. | $658.18 | 49 | $0 (2024) |
| Lilly USA, LLC | $205.71 | 12 | $0 (2024) |
| PFIZER INC. | $165.54 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $107.50 | 7 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.69 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $78.92 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $68.59 | 3 | $0 (2023) |
| Amarin Pharma Inc. | $50.47 | 3 | $0 (2021) |
| Exact Sciences Corporation | $49.95 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $865.10 | 50 | ABBVIE INC. ($286.00) |
| 2023 | $725.85 | 45 | ABBVIE INC. ($293.35) |
| 2022 | $581.72 | 29 | Novo Nordisk Inc ($251.93) |
| 2021 | $428.68 | 21 | Novo Nordisk Inc ($180.64) |
| 2019 | $22.86 | 1 | Amarin Pharma Inc. ($22.86) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Obesity | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Obesity | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: RESPIRATORY | ||||||
| 06/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $114.15 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 426 | 525 | $57,396 | $19,909 |
| 2022 | 10 | 529 | 594 | $49,196 | $17,893 |
| 2021 | 11 | 581 | 657 | $57,875 | $22,588 |
Total Patients
1,536
Total Services
1,776
Medicare Billing
$60,390
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 147 | $31,887 | $9,621 | 30.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $9,300 | $3,982 | 42.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 63 | $9,112 | $3,094 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 84 | 122 | $2,318 | $1,025 | 44.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,045 | $791.23 | 75.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $660.00 | $433.05 | 65.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 49 | 53 | $1,219 | $403.33 | 33.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 24 | 29 | $841.00 | $276.08 | 32.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 21 | 22 | $814.00 | $227.70 | 28.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 25 | $200.00 | $55.00 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 84 | $16,212 | $5,466 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $10,763 | $4,911 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 87 | $11,310 | $4,547 | 40.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 73 | 80 | $2,960 | $833.73 | 28.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 76 | 84 | $1,932 | $639.13 | 33.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 39 | 40 | $1,800 | $528.24 | 29.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 85 | 112 | $2,128 | $331.23 | 15.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,056 | $304.06 | 28.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 31 | $899.00 | $294.70 | 32.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $136.00 | $37.65 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 111 | 137 | $25,756 | $10,293 | 40.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $10,076 | $4,699 | 46.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 73 | 83 | $10,624 | $4,355 | 41.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 68 | 73 | $2,701 | $770.88 | 28.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 85 | 92 | $2,116 | $707.07 | 33.4% |
About Joslin John, FNP
Joslin John, FNP is a Family healthcare provider based in Buford, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2019. The National Provider Identifier (NPI) number assigned to this provider is 1508417361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joslin John, FNP has received a total of $2,624 in payments from pharmaceutical and medical device companies, with $865.10 received in 2024. These payments were reported across 146 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,624).
As a Medicare-enrolled provider, John has provided services to 1,536 Medicare beneficiaries, totaling 1,776 services with total Medicare billing of $60,390. Data is available for 3 years (2021–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Buford, GA
- Active Since 09/24/2019
- Last Updated 02/15/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1508417361
Products in Payments
- VRAYLAR (Drug) $503.96
- Wegovy (Drug) $296.09
- Saxenda (Drug) $177.43
- Ozempic (Drug) $166.71
- UBRELVY (Drug) $128.23
- Rybelsus (Drug) $103.07
- MOUNJARO (Drug) $102.62
- NURTEC ODT (Drug) $82.03
- JARDIANCE (Drug) $74.52
- Kerendia (Drug) $68.59
- FARXIGA (Drug) $64.22
- ELIQUIS (Drug) $51.41
- Vascepa (Drug) $50.47
- Cologuard Collection Kit (Device) $49.95
- LEQVIO (Drug) $49.90
- SHINGRIX (Biological) $45.19
- TRADJENTA (Drug) $41.55
- Dayvigo (Drug) $38.65
- EMGALITY (Drug) $33.58
- SOLIQUA 100/33 (Biological) $32.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Buford
Han Bi Hong
Family — Payments: $9,513
Family $9,513
Dr. Christian Gibbs, Dnp, Fnp-C, DNP, FNP-C
Family — Payments: $7,486
Family $7,486
Dr. Helen Heiskell, Np, NP
Family — Payments: $4,473
Family $4,473
Lucy Sorto, Np, NP
Family — Payments: $4,417
Family $4,417
Dena Patel, Fnp, FNP
Family — Payments: $3,078
Family $3,078
Hiroyuki Tada
Family — Payments: $2,496
Family $2,496